Results 61 to 70 of about 73,668 (355)
JTCVS Open, 2022 Background: Patients with a left ventricular assist device with right ventricular failure are prioritized on the heart transplant waitlist; however, their post-transplant survival is less well characterized.
Yaron D. Barac, MD, PhD +7 more
doaj
Implication of Hemodynamic Assessment during Durable Left Ventricular Assist Device Support
Medicina, 2020 Durable left ventricular assist device therapy has improved survival in patients with advanced heart failure refractory to conventional medical therapy, although the readmission rates due to device-related comorbidities remain high.
Teruhiko Imamura, Nikhil Narang
doaj +1 more source
Cavopulmonary assist for the failing Fontan circulation: impact of ventricular function on mechanical support strategy [PDF]
, 2014 Mechanical circulatory support--either ventricular assist device (VAD, left-sided systemic support) or cavopulmonary assist device (CPAD, right-sided support)--has been suggested as treatment for Fontan failure.
Chen, Jun +6 more
core +1 more source
COVID-19 Induced Right Ventricular Failure and Right Ventricular Assist Device Support [PDF]
, 2023 COVID-19, while primarily recognized for its pulmonary and systemic manifestations, afflicts the cardiovascular system through various abnormalities. Notably, right ventricular (RV) involvement leading to dysfunction and failure is a manifestation seen ...
Slepian, Marvin, M.D.
core +1 more source
Outcomes After Extracorporeal Right Ventricular Assist Device Combined With Durable Left Ventricular Assist Device Support [PDF]
The Annals of Thoracic Surgery, 2018 Right heart failure occurs in 9% to 44% of left ventricular assist device (LVAD) implants, of which less than 10% require right ventricular assist device (RVAD) support either concurrently with the LVAD or staged, as a delayed procedure. We have reported our outcomes based on whether the RVAD was placed concurrently or staged.Clinical data were ...
Maziar Khorsandi +10 more
openalex +4 more sources
Right ventricular assist device with membrane oxygenator support for right ventricular failure following implantable left ventricular assist device placement [PDF]
European Journal of Cardio-Thoracic Surgery, 2015 Cardiogenic shock from refractory right ventricular (RV) failure during left ventricular assist device placement is associated with high morbidity and mortality. The addition of extracorporeal membrane oxygenation to RV mechanical assistance may help RV recovery and lead to improved outcomes.We retrospectively reviewed all implanted continuous-flow ...
Jennifer M. Bell +5 more
openaire +2 more sources
Interactive Cardiovascular and Thoracic Surgery, 2021 OBJECTIVES Between 10% and 40% of patients who receive a left ventricular assistance device (LVAD) suffer from right ventricular failure (RVF) shortly after the device is implanted. Patients with post-LVAD RVF tend to have poor outcomes.
L. Chriqui +3 more
semanticscholar +1 more source
Frontiers in Cardiovascular Medicine, 2022 Right heart failure is a major cause of morbidity and mortality following left ventricular assist device implantation. Over the past few decades, the definition proposed by the Interagency Registry of Mechanical Circulatory Support and Society of ...
S. Hall, H. Copeland, A. Alam, S. Joseph
semanticscholar +1 more source
Percutaneous Mechanical Right Ventricular Support [PDF]
, 2022 Ventricular assist devices are used in patients with heart failure refractory to standard management. Though left ventricular assist devices are more often used, patients with severe right ventricular dysfunction may also be treated with mechanical ...
Cecchini, Amanda +3 more
core +1 more source
Resuscitation Plus, 2023 Background: Recent studies describe an emerging role for percutaneous left ventricular assist devices such as Impella CP® as rescue therapy for refractory cardiac arrest.
Adam L. Gottula +9 more
doaj